bluebird ceo defends $1.8 million price tag for gene therapy drug
Published 4 years ago • 3.4K plays • Length 4:25Download video MP4
Download video MP3
Similar videos
-
2:51
how this $1.8 million drug is trying to disrupt the drug pricing system
-
1:15
bluebird bio ceo defends $1.8 million price for gene therapy — 'it's really thinking about it differ
-
2:47
novartis to release new gene therapy drug that could cost $2 million
-
4:29
elevatebio ceo on disruptive potential for gene and cell therapies
-
0:48
fda greenlights first gene-editing treatment, casgevy, for sickle cell disease
-
38:55
testing a gene therapy to cure hiv & fundamentally change healthcare with jeff galvin of american...
-
7:27
crispr and bluebird bio: which is best for investors?
-
6:31
softbank ceo: we've invested around $65-$70 billion
-
1:15
bluebird bio stock falls after fda approves gene therapy
-
3:56
bluebird stock pops after fda approves its gene therapy drug
-
0:18
bluebird bio: best place to work
-
11:02
vita coco: my billion-dollar coconut water company
-
2:02
$2m gene therapy drug
-
1:01
fda approves novartis gene therapy for rare genetic disorder
-
3:02
uniqure ceo discusses company's positive data in hemophilia gene therapy treatment
-
9:56
talks at gs – nick leschly: the promise of gene therapy
-
6:44
spark therapeutics ceo on breakthroughs in gene therapy
-
0:26
bluebird has completed the first commercial cell collection for lyfgenia #bluestock #geneediting
-
5:41
who pays for a $2 million life-saving drug?
-
6:41
former fda commissioner dr. scott gottlieb on the future of gene therapy
-
6:26
sangamo therapeutics ceo: alzheimer's and parkinson's gene therapies | mad money | cnbc
-
3:39
crispr therapeutics ceo: science in gene editing is moving at break-neck speed